WEGE Secures Project to Construct Coordinating Ministry for Maritime and Investment Affairs Office Complex at IKN ACN Newswire

WEGE Secures Project to Construct Coordinating Ministry for Maritime and Investment Affairs Office Complex at IKN

JAKARTA, Feb 2, 2023 - (ACN Newswire via SEAPRWire.com) - PT Wijaya Karya Bangunan Gedung Tbk (WEGE) has secured another project at the new capital city (Ibu Kota Negara, IKN) in East Kalimantan to construct the office complex for the Coordinating Ministry for Maritime and Investment Affairs (Kementerian Koordinator Kemaritiman dan Investasi, Kemenkomarves). The project was valued at Rp745 billion. WEGE has previously secured a project to construct modular buildings to house construction workers at IKN, and its progress has reached 94%.A highlight of the eight storey Kemenkomarves office is it features integrated Smart and Green Building concept.Another highlight is that the construction of the Kemenkomarves Office will implement Building Information Modelling (BIM) technology. The Kemenkomarves Office is located at Sepaku, Penajam Paser Utara and will not be far from the IKN Presidential Office.WEGE's scope of work in this project is design-build construction with a completion period of 660 working days. The Kemenkomarves office complex will cover an area of 24,274 square metres.WEGE Carries Out Groundbreaking of BMKG State College that Applies Smart and Green Building ConceptWEGE held a groundbreaking ceremony of the Lecture and Laboratory Building (Centre of Excellence) for the departments of Meteorology, Climatology, Geophysics, and Instrumentation (MKGI) of the State College of Meteorology Climatology and Geophysics (STMKG) in Tangerang.The groundbreaking ceremony was held on Monday (24/01) and attended by the Head of Meteorological, Climatological, and Geophysical Agency (BMKG), Dwikorita Karnawati; Head of STMKG, I Nyoman Sukanta; representative of the Tangerang City Government; President Director of WEGE, Hadian Pramudita; Director of QHSE and Marketing, Yulianto; and Director of Operations I, Bagus Tri Setyana."We hope that through Smart and Green Building concept, BMKG is contributing to reducing and controlling CO2 emissions," said the Head of BMKG, Dwikorita Karnawati in her speech.WEGE was trusted by BMKG to construct the MKGI Lecture and Laboratory Building (Centre of Excellence) located at Jalan Meteorologi No. 5, Tanah Tinggi, Tangerang, Banten.This modern campus with the Smart and Green Building concept is scheduled for completion in 350 calendar days or at the end of 2023. Construction of this BMKG state college implemented level 5D of BIM technology to support the acceleration, construction accuracy, and safety and security factors.WEGE's scope of work in this project includes planning, preparation, structural work, architectural work, mechanical, electrical & plumbing (MEP) work, and landscaping.This STMKG facility will be 39 metres high, consisting of eight floors and one basement level with a total building area of 31,540 square metres.In addition to constructing a lecture building, there will be an MKGI Laboratory (Centre of Excellence) which targets the Excellent category in Green Building Certification.This is one of BMKG's mega projects in training experts to support BMKG's duty in providing information on meteorology, climatology, geophysics, and air quality to the Indonesian people.PT Wijaya Karya Bangunan Gedung Tbk [IDX: WEGE]Contact: Purba Yudha TamaCorporate Secretary PT Wijaya Karya Bangunan Gedung Tbk. Mobile: 0813 1792 5577Phone: +6221 85908862 / 85909003Email: corsec@wikagedung.co.id Copyright 2023 ACN Newswire. All rights reserved. (via SEAPRWire)
More
LUI Che Woo Prize donates RMB 250 million to support the development of Shanghai Jiao Tong University Zhangjiang Science Park, The new campus is named Lui Che Woo Science Park ACN Newswire

LUI Che Woo Prize donates RMB 250 million to support the development of Shanghai Jiao Tong University Zhangjiang Science Park, The new campus is named Lui Che Woo Science Park

HONG KONG, Dec 20, 2022 - (ACN Newswire via SEAPRWire.com) - Dr Lui Che-woo, Chairman of K. Wah Group (the "Group") and the founder of LUI Che Woo Prize - Prize for World Civilization ("LUI Che Woo Prize"), has donated RMB 250 million through the LUI Che Woo Prize to support the development of Shanghai Jiao Tong University ("SJTU") Zhangjiang Science Park and contribute to national science and technology development. To thank Dr Lui for his generous donation, the new campus will be named Lui Che Woo Science Park. The agreement signing ceremony was held in Hong Kong today, guests including HKSAR Chief Executive John Lee who gave a video speech; former Chief Executive Carrie Lam, Executive Director of K. Wah International Holdings Limited ("KWIH") Alexander Lui, Executive Director of KWIH and member of board of trustees of SJTU Paddy Lui, Secretary of the CPC SJTU Committee Yang Zhen Bin; and Vice President of SJTU Zhang An Sheng. Professor Lin Zhong Qin, President of SJTU, and other university leaders participated in the ceremony via webcast. After the ceremony, Professor Ding Kui Ling, Executive Vice President of SJTU, Academician of the Chinese Academy of Sciences and Dean of the Zhangjiang Institute for Advanced Study, delivered a keynote speech on China's Forefront Science and Technology Development through a live webcast to promote the exchange of science and technology development and ties between Shanghai and Hong Kong.A rendering of Lui Che Woo Science Park in completion.1. Lui Che Woo Science Park Block 1: AI Biomedicine Centre, DNA Storage and Research Centre; 2. Block 2: Integrated Scientific Innovation Research Centre; 3. Block 3: AI Cybersecurity Innovation Centre; 4. Block 4: Frontiers Science Centre for Transformative Molecules, Future Material Creation Centre; 5. Block 5: Ultra-Fast Science Centre; 6. Science Park Complex; 7. Teacher and student dormitory; 8. Teacher and student dormitory; 9. The adjacent Shanghai Synchrotron Radiation FacilityDr Lui Che-woo, Chairman of K. Wah Group and the founder of LUI Che Woo Prize - Prize for World Civilization (middle) and Yang Zhen Bin (2nd left), Secretary of the CPC SJTU Committee sign the donation agreement, accompanied by Alexander Lui (2nd right), Executive Director of K. Wah International Holdings Limited; Paddy Lui (1st right), Executive Director of K. Wah International Holdings Limited and member of board of trustees of SJTU; and Zhang An Sheng (1st left), Vice President of SJTU.Dr Lui Che-woo, Chairman of K. Wah Group and the founder of LUI Che Woo Prize - Prize for World Civilization (1st row – 2nd right), Yang Zhen Bin (1st row - 2nd left), Secretary of the CPC Shanghai Jiao Tong University ("SJTU") Committee, former chief executive Carrie Lam (1st row – 1st right), Zhang An Sheng (1st row – 1st left), Vice President of SJTU, take a group photo with the representatives from the LUI Che Woo Prize, members of board of trustees, and representatives from the SJTU.Dr Lui Che-woo, Chairman of K. Wah Group and the founder of LUI Che Woo Prize - Prize for World Civilization delivers a speech.John Lee, HKSAR Chief Executive, gives a video speechThe agreement signing ceremony was webcast live at the lecture hall of the "Lui Che Woo Science Park" of Shanghai Jiao Tong University.Nurture new generations of scientists with SJTU to benefit mankind through scientific research and development ("R&D")SJTU is a well-known comprehensive university located in Shanghai. It plays a crucial role in the national innovation strategy and supports technological development, with a profound impact on the future of China and the wellbeing of people. In 2014, President Xi Jinping expressed hope of developing Shanghai into a technological innovation hub. The National Development and Reform Commission and the Ministry of Science and Technology then accelerated the construction of a technological innovation centre in the Zhangjiang area. Located in Zhangjiang, Lui Che Woo Science Park will be key for SJTU as it actively plays a part in constructing a national science centre in the area, and from which to build a world-class R&D base by promoting technological innovation and extensive integration with economic and social development, thus further strengthening China's international presence and influence in relevant fields. Dr Lui Che-woo, Chairman of K. Wah Group and the founder of LUI Che Woo Prize - Prize for World Civilization said, "SJTU is recognised for being one of the premier education institutions in China. It is renowned both at home and abroad, and has the longest history - stretching more than 120 years. Moreover, it has nurtured countless talent with adherence to its motto of "Gratitude and Responsibility". I am looking forward to the development of Lui Che Woo Science Park as it gradually becomes an internationally influential technological innovation centre, creating synergies with large-scale national science facilities and pursuing new R&D breakthroughs with other science parks. This includes the Shanghai Synchrotron Radiation Facility ("SSRF") nearby, which is one of the world's top five synchrotron light source projects and is engaged in the creation of new materials from atomic and molecular structures that are the fundamental of science."Yang Zhen Bin, Secretary of the CPC SJTU Committee, thanked Dr Lui for his generous support for the university, and said, "Dr Lui Che-woo selflessly promotes the advancement of mankind and encourages technological innovation through extraordinary wisdom. His assistance in the development of Lui Che Woo Science Park will boost the national technological innovation strategy and education development at SJTU. Lui Che Woo Science Park will lead SJTU as it integrates into the Zhangjiang Comprehensive National Science Centre and participates in the construction of a globally influential technological innovation centre. Through the steadfast attention of Dr Lui Che-woo and his family, we believe that Lui Che Woo Science Park will grow into an innovative platform for cross-disciplinary research; achieving major scientific breakthroughs, attracting top and innovative talent and utilising industrial technologies. "Optimise R&D conditions to attract and train professionals and consolidate China's international position in the R&D field As the primary technological innovation centre in Shanghai and a top national high-tech base, Zhangjiang Science Park possesses sizeable and comprehensive facilities, platforms, and superb institutes. Lui Che Woo Science Park is positioned as a world-class influential technological innovation centre, and is set to create a strong cluster effect with other large-scale national scientific facilities in the area. It is expected to promote the leapfrog development of multiple disciplines in China, build a cutting-edge interdisciplinary research platform, and become the centre for gathering top scientists. Lui Che Woo Science Park covers a GFA of over 100,000 square meters, half of which is for R&D use. There are eight buildings in total, housing more than 1,200 researchers from various disciplines which includes approximately 600 researchers, postdoctoral fellows, and about 600 researchers with doctoral and master degrees. They will mainly focus on the R&D of health, biomedical engineering and new materials.Seven centres and one platform support interdisciplinary scientific researchLui Che Woo Science Park houses seven research centres, including the AI Biomedicine Centre, DNA Storage and Research Centre, Integrated Scientific Innovation Research Centre, AI Cybersecurity Innovation Centre, Frontiers Science Centre for Transformative Molecules, Future Materials Creation Centre and Ultra-Fast Science Centre. Upon completion, the park will facilitate the construction of the Zhangjiang Comprehensive National Science Centre and drive China's fundamental R&D and related industrial development in interdisciplinary fields, such as physics, materials, biology, medicine and network, and so on.To facilitate collaboration among the seven research centres, the Lui Che Woo Science Park has built a public instrument platform, which currently has 65 sets of equipment worth a total of RMB137 million. It also boasts around 1,300 square meters of laboratory space, which will help further raise the standard of fundamental technologies, including element, organic molecule and molecular function analysis; providing greater and broader technical support for SJTU in terms of the detection and characterisation of such areas as organic chemistry, pharmacy, life science, medicine and material science. Furthermore, the instruments are available for teachers and students at SJTU to build a user-oriented training system. Technical training and exchanges will also be held regularly.Collaborates with SSRF to realize research results at Frontiers Science Centre for Transformative Molecules ("FSCTM")The Lui Che Woo Science Park is adjacent to SSRF, which has one of the world's top five synchrotron light source projects. The two parties have formed a strategic partnership and will cooperate in research into new molecules and materials. SSRF possesses operations that comparable to powerful "super X-ray machines" and "super microscopes", which can be used for researching in medicine, physics, science and so on.With the support from SSRF, the FSCTM at Lui Che Woo Science Park has developed the ultra-fast in-situ characterization technology. Through molecular electricity catalysis, new substances or materials can be developed for applications in medicine, clean energy and green chemicals. In 2022, results from the research team at the centre have been published by top international academic journals, such as Nature and Science.Enhances technological innovation and assists the country in implementing innovation-driven development strategiesDr Lui shares President Xi Jinping's thoughts that "science and technology are having a profound impact on the future of the country as well as on people's wellbeing like never before". He believes that there is an urgency to strengthen technological innovation to help the country play a major role in implementing development strategies and accelerating the replacement of traditional strategies with new ones.Having participated in philanthropy for nearly half a century, Dr Lui has been focusing on the support for education sector to align with the pace of national development. In particular, he is keen on supporting advanced scientific research and development in recent years, with the hope of contributing to the growth of the country. Dr Lui donated RMB120 million to the School of Life Sciences at Peking University in 2017 and RMB200 million to Tsinghua University in 2018 for the construction of two new blocks at the Biomedical Sciences Building, demonstrating his commitment to boosting life sciences development. Following these two donations, Dr Lui donated RMB250 million to SJTU to fund the construction of Lui Che Woo Science Park to support China's new and high-tech research development.Dr Lui concluded, "I migrated to Hong Kong at the age of four and have established K. Wah Group for nearly seven decades. Having witnessed the achievements of our motherland and Hong Kong in the new century, I was buoyed to uphold the belief of 'giving back to society from which one has benefited'. Technology has been developing at a rocket pace and will serve as the lifeline to people and civilization in the future. I am honoured to support SJTU's establishment of Lui Che Woo Science Park, and I hope its cutting-edge facilities and talent will contribute to scientific research and development in Shanghai and across China. I believe that the collaboration and exchange with international scientific research institutions will also boost the stature of China's scientific research in the global arena."About LUI Chi Woo PrizeFounded by Dr Lui Che-woo in 2015, the "LUI Che Woo Prize - Prize for World Civilisation" is an annual, first of its kind international cross-sector innovative award for advancing world civilisation and inspiring people to build a more harmonious world. It aims to recognise and honour individuals or organisations all over the world for outstanding contributions and encourages the continuation of that work in three objectives: sustainable development of the world, betterment of the welfare of mankind and promotion of positive life attitude and enhancement of positive energy.For more details, please go to www.luiprize.org.About K. Wah GroupK. Wah Group was founded in 1955 by Dr Lui Che-woo, who transformed the company into a multinational corporation. Core businesses include property development and investment, entertainment and leisure resorts, hospitality and construction materials. The Group has a business presence in Mainland China, Hong Kong, Macau, Southeast Asia and major cities in the US. The Group includes two Hong Kong-listed flagships: K. Wah International Holdings Limited ("KWIH"; HK stock code: 00173) and Galaxy Entertainment Group Limited ("GEG"; HK stock code: 00027 and a member of the Hang Seng Index) and over 200 subsidiaries, includes Stanford Hotels International and K. Wah Construction Materials Limited.Website: http://www.kwah.comMedia Enquiries:K. Wah GroupHelen Cheung Tel: (852) 2960 3739 Email: helencheung@kwah.com Jenny Tse Tel: (852) 2960 3101 Email: jennytse@kwah.com Andrey Leung Tel: (852) 2960 3364 Email: andreyleung@kwah.com Fax: (852) 2811 9710Lui Che Woo Prize - Prize for World CivilizationBrenda Kan Tel: (852) 2960 3791 Email: brendakan@luiprize.orgStrategic Financial Relations LimitedIris Lee Tel: (852) 2864 4829 Email: iris.lee@sprg.com.hk Shelly Cheng Tel: (852) 2864 4857 Email: shelly.cheng@sprg.com.hk Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
Handover of National Centre for Pandemic and Infection Diseases in Myanmar; Advanced Facility Built with Donation from AW Foundation ACN Newswire

Handover of National Centre for Pandemic and Infection Diseases in Myanmar; Advanced Facility Built with Donation from AW Foundation

YANGON, Myanmar, Nov 5, 2022 - (ACN Newswire via SEAPRWire.com) - AW Foundation, the philanthropic arm of Asia World Group of Companies, handed over to the Ministry of Health the newly completed Wai Bar Gi New Wing - National Centre for Infectious Diseases on 3rd Nov, 2022. Dedicated to the treatment of infectious diseases and pandemics such as COVID-19 which exerted heavy patient load on the public healthcare sector, it is the most advanced medical centre to date in Myanmar. The Newly-Constructed Wai Bar Gi New Wing- National Centre for Infectious DiseasesSide Views of Wai Bar Gi New Wing- National Centre for Infectious Diseases Interior Views of Wai Bar Gi New Wing- National Centre for Infectious Diseases Lieutenant General Aung Lin Dwe, the secretary of the State Administration Council, unveiled a plaque commemorating the handover of the three-story, 110-bed medical Centre, which was completed with a donation of 6 billion kyats and USD 3.1 million from the Foundation.The Wai Bar Gi New Wing was mooted in November 2020 by the AW Foundation team based on the personal experience of colleagues during the COVID-19 pandemic. The lack of quarantine hospitals, beds, and oxygen supply, and critically, the exposure of the devoted medical frontliners taking care of patients in general hospitals were gaps in the healthcare system evidenced during the critical period. The 51,055 square feet (4,745sqm) Centre is equipped with airflow control (negative-positive pressure), integrated oxygen access, isolation rooms, and water treatment and features that combine to make it one of the most technologically-advanced public healthcare facilities in the country. AW Foundation believes the new Centre will support the public healthcare system for the treatment of COVID-19 and any future pandemic. Construction of Centre A ground-breaking ceremony was held on-site on 5 January 2021. Construction was delayed due to a nationwide lockdown arising from the pandemic.The Centre is equipped with:- Donning and Doffing for medical staff- Staff corridors and lifts for use by Patients and Staff- Air-Conditioning and Mechanical Ventilation (ACMV) for full-time automatic disinfection of the air-flow system in the hospital building- Room communication systems and other electrical communication facilities (PABX, PA & Intercom) - Sound-Proof Generator for emergency use- Emergency response alarm systems that can automatically respond to fire and various natural disasters (fully equipped as required for an infectious disease treatment hospital)Sustainable Garden Hospital The Centre was conceptualized and constructed with deep consideration of the environment. Sustainable solar energy and the creation of new greenery at the Centre also create an environment to enhance the recovery process of patients and the well-being of the healthcare community.About AW Foundation (AWF) - Together, we can make change happenAW Foundation is a non-profit organization and the philanthropic arm of the Asia World Group of Companies. AWF supports projects that develop the well-being of the people of Myanmar, focusing on healthcare, education, disaster relief, and community development. It was established in 2014, building on a strong tradition of philanthropy of the Asia World Group of companies since 1992.AW Foundation aims to develop and advance the livelihoods of people throughout Myanmar and is passionate about exploring new projects that benefit all. Through our commitment to quality and continued efforts to help those in need, AWF strives to deliver exceptional value and improve the lives of Myanmar's citizens. https://aw-foundation.org/For media queries, please contact the AW Media Office at media@aw-foundation.org Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
EC Healthcare and AXA Jointly Establish the FIRST AXA Medical Centre ACN Newswire

EC Healthcare and AXA Jointly Establish the FIRST AXA Medical Centre

HONG KONG, Sep 8, 2022 - (ACN Newswire via SEAPRWire.com) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Group has entered into a non-legally binding memorandum of understanding (the "MOU") with AXA Hong Kong & Macau ("AXA") for a strategic partnership, pledging to work together to provide premium and comprehensive health management services to customers. EC Healthcare and AXA signed Memorandum of understanding today to kick start their long term collaboration. (From left: Emily Li, Chief Employee Benefits & Wellness Officer, AXA Hong Kong and Macau, Sally Wan, Chief Executive Officer of AXA Greater China, Eddy Tang, Founder, Chairman, Executive Director and CEO of EC Healthcare and Leslie Lu, Executive Director and Co-CEO of EC Healthcare)Under the partnership, the first AXA Medical Centre was unveiled today on the 34th floor of the World Trade Centre in Causeway Bay. Together with the AXA designated Endoscopy and Day Surgery Centre in Central, it will officially start operating in November this year.Located in the central business district of Causeway Bay, the AXA Medical Centre occupies a floor area of over 5,000 sq. ft. The center offers services include preventive medicine, body checks, vaccinations, and nutritional counselling with support from on-site medical professionals including general practitioners, Chinese medicine practitioners, dieticians and radiographers. The AXA Medical Centre provides various body check services such as chest and abdominal X-rays, ultrasound scans, gynaecological examination, electrocardiogram (ECG) with over 10 body examination rooms. Other services include allergy tests, non-invasive genetic screening tests for colorectal cancer, and all pre-insurance health screening for AXA customers.EC Healthcare is building a one-stop, multi-disciplinary, enclosed healthcare service platform, which allows AXA's customers to obtain a seamless medical referral service after check-ups and enjoy comprehensive, high-quality medical services that covers multiple medical disciplines.In addition to setting up dedicated medical centres, the Group and AXA will further their cooperation with a view to extending the market coverage of their services to other central business districts and residential areas.Mr. Leslie Lu, Executive Director and Co-CEO of EC Healthcare said, "Hong Kong's private healthcare market has huge potential. The Group regards strategic partnership with insurance firms as a key strategy of building up its presence in the growing market. The Group is very honoured to form partnership with such an internationally leading insurance group as AXA. The Group believes that the strategic partnership will boost higher customer public traffic with strong synergy in the healthcare sector and enhance the organic growth of the Group's medical and healthcare business through the provision of high-quality and high-end branding medical and healthcare services. The Group will also forge ahead with its deep strategic cooperation with the key players in the technology, telecommunications, insurance, property and pharmaceutical industries so as to keep enriching EC Healthcare's enclosed healthcare ecosystem."Ms. Sally Wan, Chief Executive Officer of AXA Greater China said, "AXA Medical Centre marks a major milestone for us in delivering exceptional health management services to our customers, providing our customers with all-round care across their life stages. The centre, offering comprehensive one-stop health management services spanning prevention, diagnosis, and treatment, not only enhanced AXA's health management ecosystem but also brought to life our ongoing commitment to become a lifelong partner to our customers. AXA and EC Healthcare share the same vision of improving our customers' holistic wellness. Through this partnership, we can bring an exclusive, innovative, and personalised healthcare experience beyond insurance to our customers leveraging our combined strength."About EC Healthcare EC Healthcare is Hong Kong's largest non-hospital medical service provider*, leveraging its core businesses of preventive and precision medicine, and committed to developing medical artificial intelligence by integrating its multi-disciplinary medical services. The move, which is supported by the Group's high-end branding and quality customer services, is aimed at offering customers safe and effective healthcare and medical services with professionalism. The Group is a constituent stock of the Hang Seng Composite Index and the MSCI Hong Kong Small Cap Index.The Group principally engages in the provision of one-stop medical and health care services in Greater China. The Group provides a full range of services and products under its well-known brands, including those of its one-stop aesthetic medical solutions provider DR REBORN which has ranked first in Hong Kong by sales for years, a professional hair care center HAIR FOREST, primary care clinics jointly established with health management centre re:HEALTH, a vaccine centre Hong Kong Professional Vaccine HKPV, General outpatient clinic Tencent Doctorwork, the largest one-stop pain management centre in Hong Kong New York Medical Group, the comprehensive dental centres Bayley & Jackson Dental Surgeons, EC DENTAL CARE and Health and Care Dental Clinic, an advanced diagnostic and imaging centre HKAI, an oncology treatment centre reVIVE, a day procedure centre HKMED, a specialty clinic PREMIER MEDICAL CENTRE, SPECIALISTS CENTRAL and NEW MEDICAL CENTER, a paediatric centre PRIME CARE, a gynaecology specialist ZENITH MEDICAL CENTER AND PRENATAL DIAGNOSIS CENTRE, PathLab Medical Laboratories, Ophthalmology Center VIVID EYE and EC Veterinary Hospital and Imaging Center.*According to independent research conducted by Frost and Sullivan in terms of revenue in 2020 and 2021For further information, please contact: iPR Ogilvy Limited Callis Lau / Lorraine Luk Tel: (852) 2136 6952 / 2169 0467 Fax: (852) 3170 6606 Email: ech@iprogilvy.com Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
EC Healthcare Provides Healthcare Services for Signature and Prestige Banking Customers of Hang Seng Bank ACN Newswire

EC Healthcare Provides Healthcare Services for Signature and Prestige Banking Customers of Hang Seng Bank

HONG KONG, Jul 18, 2022 - (ACN Newswire via SEAPRWire.com) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce the Group will provide diversified healthcare services for Signature and Prestige Banking customers of Hang Seng Bank via the brands under the Group, including New York Medical Group, Hair Forest, DR REBORN and ATO HAIR CLUB. As the leading healthcare services provider, EC Healthcare is committed to providing professional, premium and diversified medical healthcare services covering 29 medical disciplines and to bringing health, beauty and happiness to the world. EC Healthcare will safeguard the health of banking customers in line with the client-centric core value, and provide comprehensive healthcare, aesthetic and beauty and kids well-being and healthcare services for them and their children. The promotion period started from 1 July 2022 and will end till 30 June 2023.*Please refer to the [Terms and Conditions] on the Hang Seng website for detailed information.About EC Healthcare EC Healthcare is Hong Kong's largest non-hospital medical service provider*, focusing on preventive and precision medicine, the leverage investment in IT, brand, service and corporate culture aims build a diversified enclosed healthcare ecosystem, bringing health, beauty, and happiness to everyone. The Group is a constituent stock of the Hang Seng Composite Index and the MSCI Hong Kong Small Cap Index.The Group principally engages in the provision of one-stop medical and health care services in Greater China. The Group provides a full range of services and products under its well-known brands, including those of its one-stop aesthetic medical solutions provider DR REBORN which has ranked first in Hong Kong by sales for years, a professional hair care center HAIR FOREST, primary care clinics jointly established with health management centre re:HEALTH, a vaccine centre Hong Kong Professional Vaccine HKPV, General outpatient clinic Tencent Doctorwork, the largest one-stop pain management centre in Hong Kong New York Medical Group, the comprehensive dental centres Bayley & Jackson Dental Surgeons, EC DENTAL CARE and Health and Care Dental Clinic, an advanced diagnostic and imaging centre HKAI, an oncology treatment centre reVIVE, a day procedure centre HKMED, a specialty clinic Premier Medical Centre, Specialist Central and New Medical Centre, a paediatric centre PrimeCare, a gynaecology specialist Zenith Medical Centre and Paternal Diagnosis Centre, PathLab Medical Laboratories, Ophthalmology Center Vivid Eye, and EC Veterinary Hospital and Imaging Center.*According to independent research conducted by Frost and Sullivan in terms of revenue in 2020 and 2021 Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
Imperial College London and Hitachi to launch a joint research centre for decarbonisation and natural climate solutions JCN Newswire

Imperial College London and Hitachi to launch a joint research centre for decarbonisation and natural climate solutions

LONDON, Jul 12, 2022 - (JCN Newswire via SEAPRWire.com) - Imperial College London (Imperial), Hitachi, Ltd. and Hitachi Europe Ltd. (Hitachi) today announced that they have signed an agreement to establish a joint research centre for decarbonisation and natural climate solutions. Together, they will collaborate in fundamental and applied research, addressing key challenges in decarbonisation and climate repair in order to achieve a Net Zero future.The new Centre, named the "Hitachi-Imperial Centre for Decarbonisation and Natural Climate Solutions" will enable a fundamental and applied research programme to be established where Imperial and Hitachi will collaborate on selected research projects, reports and white papers on the challenges and technologies in reaching net zero, as well as potential scenarios that could arise when the world reaches net zero. The Centre will also help train the next generation of scientists and engineers in the field.Initial research projects will focus on carbon management, the decarbonisation of energy and transport, carbon dioxide removal and biodiversity, with a focus on new technologies and nature-based solutions. The Centre will be a platform to bring together researchers from different faculties and disciplines, to build a truly multidisciplinary, holistic programme, taking a systems-thinking approach to embed both technical and socio-economic/policy aspects to deliver transformative and translatable solutions.Imperial is committed to helping societies become more sustainable through bold initiatives that find meaningful solutions to climate change. Imperial's Transition to Zero Pollution initiative aims to build new partnerships between research, industry and government - from fundamental science and engineering, systems thinking, human health, new business models, and policymaking - to realise its vision of a sustainable zero pollution future.Hitachi's Environmental Vision is to realise a decarbonised and resource-efficient society in harmony with Nature, and thereby contribute to a sustainable society flourishing within planetary boundaries and enhancing human well-being. To underline its commitment to a net zero society and become a Climate Change Innovator, Hitachi joined the United Nations Race to Zero Campaign in 2020, was a principal partner of COP26, and has been advocating a holistic approach to combating climate change together with stakeholders. Building on its strong presence in the mobility and energy sectors in Europe, Hitachi will leverage the global footprint and green products portfolio of the Hitachi group to deploy economically viable impactful end-to-end green solutions.Projects under this collaboration will be steered jointly by senior representatives from both Imperial and Hitachi, including Professor Mary Ryan from Imperial's Faculty of Engineering, and Dr Kazuyuki Sugimura, CTO of Hitachi Europe Ltd.Professor Ryan, who also leads the Transition to Zero Pollution initiative, said: "There is greater urgency than ever before to tackle global pollution, of which CO2 is one of the biggest sources. This joint research centre will bring together world-leading scientists and innovators in decarbonisation and climate repair to develop new technology and solutions to the climate emergency. Imperial and Hitachi will work closely together to make significant advances in developing cleaner energy and this new centre will accelerate our work towards a zero pollution future." Dr David Green, collaboration centre lead for Hitachi and Head of the Sustainability Laboratory in the European R&D Centre of Hitachi Europe Ltd. said: "Limiting greenhouse gas emissions and reaching Net Zero is crucial. Yet even in a net zero world we will still face serious societal and environmental challenges caused by high residual levels of carbon dioxide in the atmosphere. We are excited to open our new centre with Imperial which builds on previous collaborations and harnesses their expertise in scientific research, business and policy."About Imperial College LondonImperial College London is one of the world's leading universities. The College's 22,000 students and 8,000 staff are working to solve the biggest challenges in science, medicine, engineering and business.Imperial is University of the Year 2022 in the Times and Sunday Times Good University Guide. It is the world's fifth most international university, according to Times Higher Education, with academic ties to more than 150 countries. Reuters named the College as the UK's most innovative university because of its exceptional entrepreneurial culture and ties to industry. Imperial has a greater proportion of world-leading research than any other UK university, according to the Research Excellence Framework (REF). Imperial ranks first in the UK for research outputs, first in the UK for research environment, and first for research impact among Russell Group universities.About Hitachi, Ltd.Hitachi drives Social Innovation Business, creating a sustainable society with data and technology. We will solve customers' and society's challenges with Lumada solutions leveraging IT, OT (Operational Technology) and products, under the business structure of Digital Systems & Services, Green Energy & Mobility, Connective Industries and Automotive Systems. Driven by green, digital, and innovation, we aim for growth through collaboration with our customers. The company's consolidated revenues for fiscal year 2021 (ended March 31, 2022) totalled 10,264.6 billion yen ($84,136 million USD), with 853 consolidated subsidiaries and approximately 370,000 employees worldwide. For more information on Hitachi, please visit the company's website at https://www.hitachi.com.About Hitachi Europe Ltd.Hitachi Europe Ltd., a subsidiary of Hitachi, Ltd., is headquartered in Sefton Park, UK. The company is focused on its Social Innovation Business - delivering innovations that answer society's challenges. Hitachi Europe and its subsidiary companies offers a broad range of information & telecommunication systems; rail systems, power and industrial systems; industrial components & equipment; automotive systems, digital media & consumer products and others with operations and research & development Laboratories across EMEA. For more information, visit https://www.hitachi.eu/en.For more information, use the enquiry form below to contact the Research & Development Group, Hitachi, Ltd. Please make sure to include the title of the article. www8.hitachi.co.jp/inquiry/hqrd/news/en/form.jsp Copyright 2022 JCN Newswire. All rights reserved. (via SEAPRWire)
More
EC Healthcare Received “Institutional Investor” 2022 Multiple Awards in All-Asia Executive Team Rankings ACN Newswire

EC Healthcare Received “Institutional Investor” 2022 Multiple Awards in All-Asia Executive Team Rankings

HONG KONG, Jun 27, 2022 - (ACN Newswire via SEAPRWire.com) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce the excellent result in the "All-Asia Executive Team Rankings 2022" under the category of Healthcare & Pharmaceutical organized by Institutional Investor, an international magazine. The Group is delighted recognize as The Most Honoured Company (Healthcare & Pharmaceutical) in the division - Asia (excluding mainland China), which represents recognition of the Group's impressive performance by the investors and the market. Recognized as an authoritative ranking by industries, "All-Asia Executive Team Rankings" celebrates the outstanding companies and management teams in Asia. Buy-side and sell-side analysts rated the listed companies within the scope of their research according to several criteria used in evaluating performance in corporate governance.Category / AwardCore Asia Results / Best IR TeamAsia ex-Mainland China:The Most Honoured CompanyBest CEO - Mr. Eddy TangBest CFO - Mr. Levin LeeBest Investor Relations Program Best ESGBest Investor Relations Professional - Mr. Christopher Wong / Ms. Hermione HeAsia Small and Midcap:Best CEO - Mr. Eddy TangBest CFO - Mr. Levin LeeBest Investor Relations Program Best ESGBest Investor Relations Professional - Mr. Christopher WongMr. Eddy Tang, Chairman, Executive Director and Chief Executive Officer of EC Healthcare said, "The Group is honoured and grateful to receive these awards. We will continue to spare tremendous effort with the aim of further consolidating the leading position in the healthcare market and maximizing our shareholder value. The Group wishes to excel together with our much-valued stakeholders and stay proactive in continuously refining our strategies for the overall welfare of our company and the greater community."About EC Healthcare EC Healthcare is Hong Kong's largest non-hospital medical service provider*, leveraging its core businesses of preventive and precision medicine, and committed to developing medical artificial intelligence by integrating its multi-disciplinary medical services. The move, which is supported by the Group's high-end branding and quality customer services, is aimed at offering customers safe and effective healthcare and medical services with professionalism. The Group is a constituent stock of the Hang Seng Composite Index and the MSCI Hong Kong Small Cap Index.The Group principally engages in the provision of one-stop medical and health care services in Greater China. The Group provides a full range of services and products under its well-known brands, including those of its one-stop aesthetic medical solutions provider DR REBORN which has ranked first in Hong Kong by sales for years, a professional hair care center HAIR FOREST, primary care clinics jointly established with health management centre re:HEALTH, a vaccine centre Hong Kong Professional Vaccine HKPV, General outpatient clinic Tencent Doctorwork, the largest one-stop pain management centre in Hong Kong New York Medical Group, the comprehensive dental centres Bayley & Jackson Dental Surgeons, EC DENTAL CARE and Health and Care Dental Clinic, a advanced diagnostic and imaging centre HKAI, an oncology treatment centre reVIVE, a day procedure centre HKMED, a specialty clinic PREMIER MEDICAL CENTRE, SPECIALISTS CENTRAL and NEW MEDICAL CENTER, a paediatric centre PRIME CARE, a gynaecology specialist ZENITH MEDICAL CENTER AND PRENATAL DIAGNOSIS CENTRE, PathLab Medical Laboratories, Ophthalmology Center VIVID EYE and EC Veterinary Hospital and Imaging Center.*According to independent research conducted by Frost and Sullivan in terms of revenue in 2020 and 2021 Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More